Bicocca Open Archive

Logo unimib boa
POZZI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.222
AS - Asia 9.167
EU - Europa 5.940
SA - Sud America 1.029
AF - Africa 196
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.605
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.597
SG - Singapore 2.696
VN - Vietnam 2.454
CN - Cina 1.774
IT - Italia 1.617
DE - Germania 961
HK - Hong Kong 896
RU - Federazione Russa 853
BR - Brasile 784
SE - Svezia 548
CA - Canada 517
GB - Regno Unito 386
IE - Irlanda 352
FR - Francia 257
IN - India 253
KR - Corea 215
FI - Finlandia 176
ID - Indonesia 136
AT - Austria 133
BD - Bangladesh 133
NL - Olanda 104
UA - Ucraina 101
JP - Giappone 100
AR - Argentina 94
TR - Turchia 91
IQ - Iraq 82
LT - Lituania 75
DK - Danimarca 74
ES - Italia 73
MX - Messico 62
PL - Polonia 55
CH - Svizzera 52
ZA - Sudafrica 52
PK - Pakistan 51
SA - Arabia Saudita 44
AU - Australia 39
EG - Egitto 39
BE - Belgio 36
EC - Ecuador 35
MY - Malesia 32
CO - Colombia 31
PH - Filippine 31
VE - Venezuela 27
PY - Paraguay 22
TW - Taiwan 22
RO - Romania 20
MA - Marocco 19
IR - Iran 18
TH - Thailandia 18
AE - Emirati Arabi Uniti 16
ET - Etiopia 16
UZ - Uzbekistan 16
CL - Cile 14
CZ - Repubblica Ceca 13
KZ - Kazakistan 13
DZ - Algeria 12
JO - Giordania 12
OM - Oman 12
IL - Israele 11
TN - Tunisia 11
KE - Kenya 10
BO - Bolivia 9
HN - Honduras 9
UY - Uruguay 8
AO - Angola 7
CR - Costa Rica 7
EU - Europa 7
PS - Palestinian Territory 7
RS - Serbia 7
AZ - Azerbaigian 6
BG - Bulgaria 6
HR - Croazia 6
NG - Nigeria 6
NI - Nicaragua 6
NP - Nepal 6
HU - Ungheria 5
PA - Panama 5
AL - Albania 4
BN - Brunei Darussalam 4
GR - Grecia 4
JM - Giamaica 4
KG - Kirghizistan 4
LV - Lettonia 4
NO - Norvegia 4
PE - Perù 4
SN - Senegal 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
KW - Kuwait 3
LY - Libia 3
MD - Moldavia 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CU - Cuba 2
Totale 27.575
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.752
Singapore 1.617
Dallas 1.516
Ashburn 938
Hong Kong 862
San Jose 781
Ho Chi Minh City 742
Milan 598
Hanoi 591
Frankfurt am Main 566
Toronto 378
Wilmington 345
Los Angeles 343
Dublin 340
Chandler 319
New York 318
Beijing 251
Dearborn 229
Santa Clara 211
Hefei 195
Chicago 187
Seoul 177
Munich 165
Houston 155
Woodbridge 152
Boardman 146
Princeton 134
Fairfield 130
The Dalles 130
Council Bluffs 128
Nanjing 119
Helsinki 115
Vienna 110
Jakarta 101
Buffalo 95
Lauterbourg 93
Moscow 91
Shanghai 91
Seattle 86
Orem 82
Da Nang 81
São Paulo 79
Guangzhou 76
Jacksonville 73
Haiphong 64
Tokyo 60
Vilnius 58
Ha Long 56
Hải Dương 53
Rome 52
Denver 50
Basingstoke 49
Chennai 49
Dong Ket 49
London 46
Montreal 46
Biên Hòa 45
Amsterdam 43
Baghdad 43
Warsaw 43
Carate Brianza 38
Zurich 38
Ninh Bình 36
Pune 36
Atlanta 35
Bắc Ninh 35
Can Tho 35
Rio de Janeiro 35
Brooklyn 34
Nuremberg 34
Quận Bình Thạnh 34
Poplar 33
Kent 31
Stockholm 31
Lawrence 30
Nanchang 30
Shenyang 30
Vũng Tàu 30
Cambridge 29
Phoenix 29
Altamura 28
Hangzhou 27
Melzo 27
Mexico City 26
Turku 26
Manchester 25
Thái Nguyên 25
Bắc Giang 23
San Francisco 23
Johannesburg 22
Brussels 21
Falls Church 21
Florence 21
Lappeenranta 21
Ottawa 21
Shangdi 21
Quận Một 20
Tianjin 20
Zhengzhou 20
Paris 19
Totale 17.614
Salva come PNG Salva come JPEG
Nome #
CIPN and its mechanism of development 625
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 579
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 509
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 454
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 446
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 444
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 429
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 427
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 423
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 420
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 413
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 399
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 390
OXALIPLATIN-INDUCED PERIPHERAL NEUROTOXICITY IN MOUSE MODELS: DIFFERENT TREATMENT SCHEDULES AND FOCUS ON OXIDATIVE STRESS 388
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 384
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 381
Ion Channel and Transporter Involvement in Chemotherapy-Induced Peripheral Neurotoxicity 375
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 373
Investigation of Supraspinal Plasticity in a Rat Model of Painful Paclitaxel-induced Peripheral Neuropathy 361
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 359
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 349
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 346
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 337
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 331
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 324
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 320
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 316
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 312
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 307
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 306
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 306
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 304
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 304
EVALUATION OF SATELLITE GLIAL CELLS CHANGES IN DORSAL ROOT GANGLIA IN CHEMOTHERAPY-INDUCED NEUROTOXICITY MODELS 301
An in vivo and in vitro neurophysiological approach to acute and chronic oxaliplatin-induced peripheral neurotoxicity 301
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 299
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 297
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 293
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 292
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 287
In vivo study of Carfilzomib-Induced Neuropathy 281
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 278
Morphological and functional study of the caudal nerve in a rat model of peripheral neuropathy 274
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 274
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 271
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 270
Oxaliplatin induced peripheral neurotoxicity (OIPN) and ion unbalance: the perilous link between acute and chronic neurotoxicity. 269
Multimodal experimental approach to the study of human neurological diseases 268
MORPHOLOGICAL AND METABOLOMIC CHANGES IN PIPN 265
Satellite Glial Cells in Chemotherapy Induced Peripheral Neuropathy 264
NEUROINFLAMMATION AS A POTENTIAL TARGET FOR CIPN DIAGNOSTIC AND TREATMENT 261
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 261
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 253
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 252
Studying the caudal nerve anatomy and physiology to refine detection of peripheral nerve damage in rodent models. 249
Central and peripheral neoangiogenesis in paclitaxel-induced painful peripheral neuropathy 248
Genetic factors influencing the development of vincristine-induced neurotoxicity 247
Paclitaxel alters angiogenesis in the peripheral and central nervous system of neuropathic rats 244
Inhibition of NHE1 transport activity and gene transcription in DRG neurons in oxaliplatin-induced painful peripheral neurotoxicity 242
7T MRI first exploitation in a chemotherapy induced peripheral neurotoxicity in vivo model. 241
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 233
ACCURATE NEUROPHYSIOLOGICAL MONITORING FOR SENSORY NEUROPATHY IN MOUSE MODELS OF CHEMOTHERAPY INDUCED PERIPHERAL NEUROTOXICITY 229
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 229
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 224
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 223
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 221
Metabolomics assessment in a mice model ofoxaliplatin-induced peripheral neurotoxicity 220
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 220
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 220
Oxaliplatin neurotoxicity: morpho-functional approach 217
The relevance of morphology in experimental oxaliplatin-induced peripheral neurotoxicity 216
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 216
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 214
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 214
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 214
Acute and chronic Oxaliplatin-induced peripheral neurotoxicity: two sides of the same coin 212
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 210
Oxaliplatin induced peripheral neurotoxicity (OIPN): a translational approach for drug discovery. 209
High resolution MRI in exploring peripheral nerve anatomy and axonal damage in rodent models 207
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 202
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 199
INVESTIGATION OF AGING EFFECTS ON NERVE DAMAGE IN AN ANIMAL MODEL OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY 197
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 196
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 187
STANDARD AND ADVANCED NEUROPHYSIOLOGY SET UP IN MOUSE MODELS: SENSORY RECORDINGS AND NERVE EXCITABILITY TESTING OF THE CAUDAL NERVE. 182
REFINEMENT OF MORPHOLOGICAL ANALYSIS OF THE CAUDAL NERVE IN A RODENT MODEL OF AXONAL DAMAGE WITH 7T MRI 174
Topiramate neuroprotectant effects against oxaliplatin induced peripheral neurotoxicity 171
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN) 170
MORPHOFUNCTIONAL CHARACTERIZATION OF CIPN 170
Neurofilament light protein: a blood biomarker of neurodegeneration in chemotherapy-induced peripheral neurotoxicity. 166
Oxaliplatin induced Peripheral Neurotoxicity (OIPN): a Rat Model that full encompasses all OIPN Phenomena 165
Nerve Excitability Testing: An In Vivo Translational Approach To Investigate Oxaliplatin Induced Peripheral Neurotoxicity Pathogenesis And Treatment 159
Oxaliplatin-Induced Peripheral Neurotoxicity: a Role for Genomics? 159
Oxaliplatin induced peripheral neurotoxicity: nerve excitability testing full profile in a long term toxicity animal study 156
Can different Mice Strains be differently susceptible to Oxaliplatin-Induced Peripheral Neuropathy? 144
New mechanisms of neurotoxicity related to oxaliplatin chemotherapy in mice 142
Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neurotoxicity 134
The Link between Bench and Bed-Side: “clinical” neurophysiological approach to a rat model of neuropathy 132
Investigation of Supraspinal Plasticity of Painful Paclitaxel-Induced Peripheral Neuropathy 130
TOPIRAMATE PREVENTS OXALIPLATIN ACUTE PERIPHERAL NEUROTOXICITY. 125
Totale 27.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.887
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.887
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021234 0 0 0 0 0 0 0 0 0 0 0 234
2021/20221.106 111 133 110 97 93 104 49 49 44 52 79 185
2022/20231.860 187 364 234 172 163 300 63 75 135 41 82 44
2023/20241.550 68 61 70 92 156 356 242 104 77 39 47 238
2024/20255.175 239 500 470 235 401 282 434 186 577 708 406 737
2025/202614.228 2.206 1.468 1.975 1.298 1.163 669 1.721 641 983 1.102 745 257
Totale 28.538